Loading...
Embecta Corp.
EMBC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$11.73
$0.35(3.08%)
Embecta Corp. (EMBC) Company Profile & Overview
Explore Embecta Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Embecta Corp. (EMBC) Company Profile & Overview
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEODevdatt Kurdikar
Contact Information
Company Facts
2,000 Employees
IPO DateMar 22, 2022
CountryUS
Actively Trading